Each filer's latest filing for 805111101 since 12/18/2024, largest first.
| Filer | % of Class | Filed | ||
|---|---|---|---|---|
|
Growth Equity Opportunities 17, LLC
13D/A
|
12.0% |
11/14/2025
Event 11/12/2025
|
||
| Growth Equity Opportunities 17, LLC | 12.0% | |||
| New Enterprise Associates 17, L.P. | 12.0% | |||
| NEA Partners 17, L.P. | 12.0% | |||
| Nea 17 GP, LLC | 12.0% | |||
| Forest Baskett | 12.0% | |||
| Ali Behbahani | 12.0% | |||
| Carmen Chang | 12.0% | |||
| Anthony A. Florence, Jr. | 12.0% | |||
| Mohamad H. Makhzoumi | 12.0% | |||
| Edward T. Mathers | 12.0% | |||
| Scott D. Sandell | 12.0% | |||
| Paul Walker | 12.0% | |||
| Rick Yang | 12.0% | |||
|
Bain Capital Life Sciences Fund II, L.P.
13D/A
|
10.0% |
3/27/2025
Event 3/25/2025
|
||
| Bain Capital Life Sciences Fund II, L.P. | 10.0% | |||
| BCIP Life Sciences Associates, LP | 10.0% | |||
| BCLS II Investco, LP | 10.0% | |||
|
Venrock Healthcare Capital Partners III, L.P.
13G/A
|
9.9% |
2/17/2026
Event 12/31/2025
|
||
| Venrock Healthcare Capital Partners III, L.P. | 9.9% | |||
| VHCP Co-Investment Holdings III, LLC | 9.9% | |||
| Venrock Healthcare Capital Partners EG, L.P. | 9.9% | |||
| VHCP Management III, LLC | 9.9% | |||
| VHCP Management EG, LLC | 9.9% | |||
| Nimish Shah | 9.9% | |||
| Bong Y. Koh | 9.9% | |||
|
Farallon Capital Partners, L.P.
13G/A
|
6.9% |
2/5/2026
Event 12/31/2025
|
||
| Farallon Capital Partners, L.P. | 1.2% | |||
| Farallon Capital Institutional Partners, L.P. | 1.9% | |||
| Farallon Capital Institutional Partners II, L.P. | 0.4% | |||
| Farallon Capital Institutional Partners III, L.P. | 0.2% | |||
| Four Crossings Institutional Partners V, L.P. | 0.3% | |||
| Farallon Capital Offshore Investors II, L.P. | 2.7% | |||
| Farallon Capital (AM) Investors, L.P. | 0.1% | |||
| Farallon Capital F5 Master I, L.P. | 0.5% | |||
| Farallon Partners, L.L.C. | 6.5% | |||
| Farallon Institutional (GP) V, L.L.C. | 0.3% | |||
| Farallon F5 (GP), L.L.C. | 0.5% | |||
| Dapice Joshua J. | 6.9% | |||
| Dreyfuss, Philip D. | 6.9% | |||
| Dunn Hannah E. | 6.9% | |||
| Fried, Richard B | 0% | |||
| Gehani, Varun N. | 6.9% | |||
| Giauque, Nicolas | 6.9% | |||
| Husen, Avner A. | 6.9% | |||
| Kim, David T. | 6.9% | |||
| Linn, Michael G. | 6.9% | |||
| Luo Patrick (Cheng) | 6.9% | |||
| Patel, Rajiv A. | 0% | |||
| Roberts, Jr., Thomas G. | 6.9% | |||
| Saito Edric C. | 6.9% | |||
| Seybold, William | 0% | |||
| Short Daniel S. | 6.9% | |||
| Spokes, Andrew J. M. | 6.9% | |||
| Warren, John R. | 6.9% | |||
| Wehrly, Mark C. | 6.9% | |||
|
Farallon Capital Management, L.L.C.
13G/A
|
6.8% |
8/14/2026
Event 6/30/2026
|
||
| Farallon Capital Management, L.L.C. | 6.8% | |||
| Farallon Capital Partners, L.P. | 0% | |||
| Farallon Capital Institutional Partners, L.P. | 0% | |||
| Farallon Capital Institutional Partners II, L.P. | 0% | |||
| Farallon Capital Institutional Partners III, L.P. | 0% | |||
| Four Crossings Institutional Partners V, L.P. | 0% | |||
| Farallon Capital Offshore Investors II, L.P. | 0% | |||
| Farallon Capital (AM) Investors, L.P. | 0% | |||
| Farallon Capital F5 Master I, L.P. | 0% | |||
| Farallon Partners, L.L.C. | 0% | |||
| Farallon Institutional (GP) V, L.L.C. | 0% | |||
| Farallon F5 (GP), L.L.C. | 0% | |||
| Dapice Joshua J. | 6.8% | |||
| Dreyfuss, Philip D. | 6.8% | |||
| Dunn Hannah E. | 6.8% | |||
| Gehani, Varun N. | 6.8% | |||
| Giauque, Nicolas | 6.8% | |||
| Husen, Avner A. | 6.8% | |||
| Kim, David T. | 6.8% | |||
| Linn, Michael G. | 6.8% | |||
| Luo Patrick (Cheng) | 6.8% | |||
| Roberts, Jr., Thomas G. | 6.8% | |||
| Saito Edric C. | 6.8% | |||
| Short Daniel S. | 6.8% | |||
| Spokes, Andrew J. M. | 6.8% | |||
| Warren, John R. | 6.8% | |||
| Wehrly, Mark C. | 6.8% | |||
|
James E. Flynn
13G
|
6.7% |
11/5/2025
Event 10/30/2025
|
||
| Deerfield Mgmt, L.P. | 6.7% | |||
| Deerfield Management Company, L.P. | 6.7% | |||
| Deerfield Partners, L.P. | 6.7% | |||
| James E. Flynn | 6.7% | |||
|
TCG Crossover GP I, LLC
13G/A
|
6.1% |
2/17/2026
Event 12/31/2025
|
||
| TCG Crossover GP I, LLC | 6.1% | |||
| TCG Crossover Fund I, L.P. | 6.1% | |||
| Chen Yu | 6.1% | |||
|
Polar Capital Holdings Plc
13G
|
5.6% |
11/16/2026
Event 9/30/2026
|
||
| Polar Capital Holdings Plc | 5.6% | |||
| Polar Capital LLP | 5.6% | |||
| BlackRock, Inc. 13G | 5.4% |
1/21/2026
Event 12/31/2025
|
||
| Under 5%, checked the "5 percent or less" box, or amended by a later filing (4) | ||||
|
Frazier Life Sciences Public Fund, L.P.
13G/A
|
4.1% |
2/13/2026
Event 12/31/2025
|
||
| Frazier Life Sciences Public Fund, L.P. | 4.1% | |||
| FHMLSP, L.P. | 4.1% | |||
| FHMLSP, L.L.C. | 4.1% | |||
| Frazier Life Sciences X, L.P. | 0.1% | |||
| FHMLS X, L.P. | 0.1% | |||
| FHMLS X, L.L.C. | 0.1% | |||
| Frazier Life Sciences XI, L.P. | 0.6% | |||
| FHMLS XI, L.P. | 0.6% | |||
| FHMLS XI, L.L.C. | 0.6% | |||
| James N. Topper | 0.1% | |||
| Patrick J. Heron | 0.1% | |||
|
Nantahala Capital Management, LLC
13G/A
|
3.6% |
2/13/2026
Event 12/31/2025
|
||
| Nantahala Capital Management, LLC | 3.6% | |||
| Wilmot B. Harkey | 3.6% | |||
| Daniel Mack | 3.6% | |||
|
Wellington Management Group LLP
13G/A
|
3.2% |
2/10/2025
Event 12/31/2024
|
||
| Wellington Management Group LLP | 3.2% | |||
| Wellington Group Holdings LLP | 3.2% | |||
| Wellington Investment Advisors Holdings LLP | 3.2% | |||
|
Vestal Point Capital, LP
13G/A
|
2.3% |
11/14/2025
Event 9/30/2025
|
||
| Vestal Point Capital, LP | 2.3% | |||
| Ryan Wilder | 2.3% | |||
| Period | Filers | Shares, Excl. Options | Value, Excl. Options |
|---|---|---|---|
| 2026 Q3 | 185 | 224 M | $1.16B |
| 2026 Q2 | 183 | 217 M | $1.34B |
| 2026 Q1 | 188 | 212 M | $1.16B |
| 2025 Q4 | 149 | 201 M | $1.21B |
| 2025 Q3 | 127 | 163 M | $582M |
| 2025 Q2 | 126 | 168 M | $382M |
| 2025 Q1 | 138 | 165 M | $457M |
| 2024 Q4 | 137 | 163 M | $500M |
| 2024 Q3 | 127 | 160 M | $680M |
| 2024 Q2 | 135 | 148 M | $597M |
| 2024 Q1 | 122 | 121 M | $603M |
| 2023 Q4 | 99 | 119 M | $559M |
| 2023 Q3 | 86 | 117 M | $441M |
| 2023 Q2 | 78 | 89.1 M | $285M |
| 2023 Q1 | 70 | 83.5 M | $163M |
| 2022 Q4 | 57 | 80.5 M | $125M |
| 2022 Q3 | 58 | 79.9 M | $124M |
| 2022 Q2 | 56 | 77.2 M | $117M |
| 2022 Q1 | 55 | 75.9 M | $99.4M |
| 2021 Q4 | 57 | 74.7 M | $92.6M |
| 2021 Q3 | 60 | 75.0 M | $104M |
| 2021 Q2 | 78 | 76.2 M | $130M |
| 2021 Q1 | 86 | 75.4 M | $158M |
| 2020 Q4 | 68 | 21.7 M | $24.9M |
| 2020 Q3 | 73 | 22.2 M | $41.6M |
| 2020 Q2 | 75 | 24.7 M | $71.7M |
| 2020 Q1 | 75 | 24.0 M | $62.8M |
| 2019 Q4 | 80 | 20.8 M | $92.7M |
| 2019 Q3 | 76 | 15.2 M | $40.2M |
| 2019 Q2 | 84 | 17.1 M | $40.6M |
| 2019 Q1 | 83 | 16.4 M | $121M |
| 2018 Q4 | 80 | 17.1 M | $129M |
| 2018 Q3 | 85 | 18.0 M | $201M |
| 2018 Q2 | 77 | 14.8 M | $167M |
| 2018 Q1 | 61 | 13.0 M | $119M |
| 2017 Q4 | 49 | 11.7 M | $173M |
| 2017 Q3 | 20 | 4.42 M | $41.5M |
| 2017 Q2 | 21 | 3.98 M | $23.4M |
| 2016 Q1 | 1 | 142 | $1.00k |